Free Trial
→ White House to reset Social Security? (From Altimetry) (Ad) Buy IBEX Stock  Free IBEX Stock Alerts

IBEX (IBEX) Financials

IBEX logo
$28.61 +0.26 (+0.92%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$29.81 +1.20 (+4.21%)
As of 09:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for IBEX

Annual Income Statements for IBEX

This table shows IBEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019 6/30/2018
Net Income / (Loss) Attributable to Common Shareholders		 34 32 21 13 7.77 11 -16
Consolidated Net Income / (Loss)		 34 32 21 13 7.77 11 -16
Net Income / (Loss) Continuing Operations		 34 32 21 13 7.77 -4.52 -21
Total Pre-Tax Income 		41 40 19 15 10 -0.90 -21
Total Operating Income		 39 40 21 17 23 6.44 -18
Total Gross Profit		 509 523 493 443 129 110 81
Total Revenue		 509 523 493 443 405 368 342
Operating Revenue		 509 523 493 443 405 368 342
Total Cost of Revenue		 0.00 0.00 0.00 0.00 277 259 261
Total Operating Expenses		 469 483 472 426 106 103 99
Selling, General & Admin Expense		 93 89 80 77 17 28 -
Depreciation Expense		 19 19 18 14 24 21 12
Other Operating Expenses / (Income)		 357 375 374 335 64 54 86
Total Other Income / (Expense), net		 1.56 -0.15 -1.25 -1.89 -13 -7.35 -3.09
Interest Expense		 0.51 0.79 1.29 1.89 - - -
Interest & Investment Income		 2.07 0.64 0.04 - - - -
Income Tax Expense		 7.33 8.74 -2.08 2.06 2.32 3.62 -0.11
Basic Earnings per Share		 $1.90 $1.74 $1.18 $0.74 - $0.00 -
Weighted Average Basic Shares Outstanding		 17.70M 18.20M 18.23M 17.65M 13.05M - -
Diluted Earnings per Share		 $1.84 $1.67 $1.15 $0.71 - ($0.36) -
Weighted Average Diluted Shares Outstanding		 18.26M 18.89M 18.72M 18.36M 13.05M - -
Weighted Average Basic & Diluted Shares Outstanding		 16.80M 18.30M 18.25M 18.40M 13.05M - -

Quarterly Income Statements for IBEX

This table shows IBEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders		 9.27 7.53 9.85 10 6.08 7.43 4.51 11 9.27 6.52
Consolidated Net Income / (Loss)		 9.27 7.53 9.85 10 6.08 7.43 4.51 11 9.27 6.52
Net Income / (Loss) Continuing Operations		 9.27 7.53 9.85 10 6.08 7.43 4.51 11 9.27 6.52
Total Pre-Tax Income 		12 9.51 13 12 7.35 8.81 8.32 13 11 7.57
Total Operating Income		 12 9.09 13 11 6.95 8.33 8.31 13 11 7.67
Total Gross Profit		 141 130 307 40 37 36 124 132 139 128
Total Revenue		 141 130 125 127 133 125 124 132 139 128
Operating Revenue		 141 130 125 127 133 125 124 132 139 128
Total Cost of Revenue		 0.00 0.00 -183 87 96 88 - 0.00 0.00 0.00
Total Operating Expenses		 129 121 295 28 30 28 116 119 128 120
Selling, General & Admin Expense		 26 26 22 24 25 23 24 22 24 19
Depreciation Expense		 4.29 4.37 4.61 4.87 4.95 5.04 5.05 4.67 4.58 4.68
Other Operating Expenses / (Income)		 99 90 - - - - 87 92 100 96
Total Other Income / (Expense), net		 -0.31 0.42 0.37 0.31 0.40 0.48 0.01 0.10 -0.16 -0.10
Interest Expense		 0.62 0.16 0.18 0.12 0.11 0.10 0.24 0.11 0.30 0.15
Interest & Investment Income		 0.31 0.58 0.54 0.43 0.51 0.59 0.25 0.21 0.14 0.05
Income Tax Expense		 2.35 1.98 3.39 1.28 1.27 1.39 3.81 1.87 2.02 1.05
Basic Earnings per Share		 $0.61 $0.45 $0.56 $0.59 $0.34 $0.41 $0.25 $0.62 $0.51 $0.36
Weighted Average Basic Shares Outstanding		 15.13M 16.88M 17.70M 17.47M 17.89M 18.29M 18.20M 18.23M 18.15M 18.14M
Diluted Earnings per Share		 $0.57 $0.43 $0.55 $0.57 $0.33 $0.39 $0.24 $0.59 $0.49 $0.35
Weighted Average Diluted Shares Outstanding		 16.46M 17.49M 18.26M 18.04M 18.44M 18.90M 18.89M 19.07M 18.86M 18.64M
Weighted Average Basic & Diluted Shares Outstanding		 13.19M 16.76M 16.80M 17.21M 17.57M 17.94M 18.30M - - -

Annual Cash Flow Statements for IBEX

This table details how cash moves in and out of IBEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019 6/30/2018
Net Change in Cash & Equivalents		 5.29 8.60 -9.01 36 9.64 -4.24 -8.42
Net Cash From Operating Activities		 36 42 40 16 52 2.20 -5.75
Net Cash From Continuing Operating Activities		 36 42 40 16 50 3.20 -6.37
Net Income / (Loss) Continuing Operations		 34 32 21 13 10 19 -16
Consolidated Net Income / (Loss)		 34 32 21 13 10 19 -16
Depreciation Expense		 19 19 18 14 24 22 12
Non-Cash Adjustments To Reconcile Net Income		 20 20 17 18 0.52 5.56 7.41
Changes in Operating Assets and Liabilities, net		 -37 -29 -16 -29 15 -44 -10
Net Cash From Investing Activities		 -8.86 -19 -26 -21 -4.84 -9.08 -5.44
Net Cash From Continuing Investing Activities		 -8.86 -19 -26 -21 -4.84 -9.08 -5.44
Purchase of Property, Plant & Equipment		 -8.86 -19 -26 -21 -4.28 -5.61 -5.19
Divestitures		 0.00 -0.09 0.00 0.00 - - -
Net Cash From Financing Activities		 -22 -14 -22 41 -34 2.55 3.19
Net Cash From Continuing Financing Activities		 -22 -14 -22 41 -34 2.55 3.19
Repayment of Debt		 -0.29 -58 -106 -128 -150 -185 -218
Repurchase of Common Equity		 -22 -0.28 -3.41 -1.07 0.00 0.00 -
Issuance of Debt		 0.24 43 88 118 129 205 224
Other Financing Activities, net		 -0.12 1.61 -0.78 -6.99 -12 -17 -3.16
Effect of Exchange Rate Changes		 -0.02 -0.61 -0.97 -0.18 -0.02 -0.32 0.20
Cash Interest Paid		 0.51 0.15 1.25 1.89 - - -
Cash Income Taxes Paid		 7.69 4.28 2.16 5.67 - - -

Quarterly Cash Flow Statements for IBEX

This table details how cash moves in and out of IBEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents		 -42 -0.42 12 1.65 -13 4.60 14 5.59 -4.77 -5.98
Net Cash From Operating Activities		 1.14 7.76 17 11 -1.64 8.68 17 14 5.29 5.56
Net Cash From Continuing Operating Activities		 1.14 7.76 17 11 -1.64 8.68 17 14 5.29 5.56
Net Income / (Loss) Continuing Operations		 9.27 7.53 9.85 10 6.08 7.43 4.51 11 9.27 6.52
Consolidated Net Income / (Loss)		 9.27 7.53 9.85 10 6.08 7.43 4.51 11 9.27 6.52
Depreciation Expense		 4.29 4.37 4.61 4.87 4.95 5.04 5.05 4.67 4.58 4.68
Non-Cash Adjustments To Reconcile Net Income		 4.56 4.08 4.86 5.46 5.03 4.37 4.82 4.99 5.68 4.96
Changes in Operating Assets and Liabilities, net		 -17 -8.22 -1.89 -9.21 -18 -8.15 3.06 -7.38 -14 -11
Net Cash From Investing Activities		 -4.32 -3.63 -2.22 -1.69 -2.89 -2.05 -3.72 -3.81 -7.95 -3.56
Net Cash From Continuing Investing Activities		 -4.32 -3.63 -2.22 -1.69 -2.89 -2.05 -3.72 -3.81 -7.95 -3.56
Purchase of Property, Plant & Equipment		 -4.32 -3.63 -2.22 -1.69 -2.89 -2.05 -3.72 -3.73 -7.95 -3.56
Net Cash From Financing Activities		 -39 -4.60 -3.15 -8.06 -8.55 -1.97 0.13 -3.91 -2.18 -7.67
Net Cash From Continuing Financing Activities		 -39 -4.60 -3.15 -8.06 -8.55 -1.97 0.13 -3.91 -2.18 -7.67
Repayment of Debt		 -1.60 -0.06 -0.09 -0.06 -0.06 -0.09 -0.06 -8.51 -33 -17
Repurchase of Common Equity		 -47 -4.81 -3.01 -8.28 -8.44 -1.83 - - - -0.28
Issuance of Debt		 9.10 0.06 0.09 0.06 0.06 0.04 0.06 4.08 30 9.36
Other Financing Activities, net		 0.16 0.21 -0.14 0.21 -0.11 -0.08 0.13 0.53 1.00 -0.06
Effect of Exchange Rate Changes		 -0.02 0.05 0.00 -0.03 0.07 -0.07 -0.10 -0.26 0.06 -0.32
Cash Interest Paid		 0.62 0.16 0.18 0.12 0.11 0.10 -0.40 0.11 0.30 0.15
Cash Income Taxes Paid		 3.40 3.38 2.26 1.41 2.93 1.09 1.36 0.95 1.86 0.12

Annual Balance Sheets for IBEX

This table presents IBEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019
Period end date 6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Total Assets		 294 293 294 274 195 188
Total Current Assets		 180 159 142 141 86 82
Cash & Equivalents		 63 57 49 58 22 8.87
Accounts Receivable		 99 86 75 83 64 73
Prepaid Expenses		 7.71 6.62 7.14 - - -
Current Deferred & Refundable Income Taxes		 9.08 5.97 6.39 - - -
Other Current Assets		 1.89 2.19 4.56 - - -
Plant, Property, & Equipment, net		 0.00 0.00 42 31 85 82
Total Noncurrent Assets		 114 135 110 101 22 21
Goodwill		 12 12 12 12 12 12
Noncurrent Deferred & Refundable Income Taxes		 4.29 4.59 9.28 4.25 2.22 2.52
Other Noncurrent Operating Assets		 98 118 89 81 4.83 3.40
Total Liabilities & Shareholders' Equity		 294 293 294 274 195 188
Total Liabilities		 128 143 181 194 179 180
Total Current Liabilities		 71 73 98 106 106 111
Short-Term Debt		 0.66 0.41 15 27 27 42
Accounts Payable		 17 19 21 55 53 47
Current Deferred Revenue		 4.75 6.41 8.60 - - -
Current Deferred & Payable Income Tax Liabilities		 6.08 3.02 2.97 3.66 3.09 1.47
Current Employee Benefit Liabilities		 31 29 33 - - -
Other Current Liabilities		 12 15 16 20 22 11
Total Noncurrent Liabilities		 57 70 83 88 73 68
Long-Term Debt		 0.87 0.60 0.66 1.80 3.78 7.18
Noncurrent Deferred Revenue		 1.13 1.38 3.99 - - -
Other Noncurrent Operating Liabilities		 55 68 78 14 7.49 2.36
Total Equity & Noncontrolling Interests		 166 150 113 81 16 8.63
Total Preferred & Common Equity		 166 150 113 81 16 8.63
Total Common Equity		 166 150 113 81 16 8.63
Common Stock		 210 205 198 158 96 96
Retained Earnings		 -11 -45 -76 -111 -110 -117
Treasury Stock		 -25 -3.68 -3.41 - - -
Accumulated Other Comprehensive Income / (Loss)		 -7.91 -6.31 -4.56 - - -

Quarterly Balance Sheets for IBEX

This table presents IBEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024
Period end date 12/31/2024 9/30/2024 3/31/2024 12/31/2023 9/30/2023
Total Assets		 272 306 290 298 295
Total Current Assets		 159 189 171 169 168
Cash & Equivalents		 20 62 51 49 62
Accounts Receivable		 121 106 103 105 90
Prepaid Expenses		 6.91 8.20 5.89 5.28 6.84
Current Deferred & Refundable Income Taxes		 8.97 10 9.13 8.37 6.20
Other Current Assets		 2.04 1.57 2.19 1.96 2.23
Plant, Property, & Equipment, net		 0.00 0.00 31 36 38
Total Noncurrent Assets		 113 118 87 93 90
Goodwill		 12 12 12 12 12
Noncurrent Deferred & Refundable Income Taxes		 5.05 4.41 4.00 4.29 4.34
Other Noncurrent Operating Assets		 97 101 71 77 74
Total Liabilities & Shareholders' Equity		 272 306 290 298 295
Total Liabilities		 164 135 130 142 139
Total Current Liabilities		 111 78 71 74 74
Short-Term Debt		 33 0.70 0.59 0.44 0.40
Accounts Payable		 20 20 18 18 18
Current Deferred Revenue		 7.22 4.87 5.40 6.46 5.92
Current Deferred & Payable Income Tax Liabilities		 4.64 5.89 3.32 3.35 3.16
Current Employee Benefit Liabilities		 33 34 31 32 33
Other Current Liabilities		 12 12 13 14 13
Total Noncurrent Liabilities		 53 57 60 68 66
Long-Term Debt		 0.70 0.80 0.82 0.56 0.58
Noncurrent Deferred Revenue		 1.12 1.08 1.30 1.63 1.50
Other Noncurrent Operating Liabilities		 51 56 57 66 64
Total Equity & Noncontrolling Interests		 109 171 159 156 156
Total Preferred & Common Equity		 109 171 159 156 156
Total Common Equity		 109 171 159 156 156
Common Stock		 212 211 209 208 206
Retained Earnings		 5.68 -3.59 -21 -31 -37
Treasury Stock		 -102 -30 -22 -14 -5.73
Accumulated Other Comprehensive Income / (Loss)		 -7.25 -6.15 -6.55 -6.13 -7.21

Annual Metrics And Ratios for IBEX

This table displays calculated financial ratios and metrics derived from IBEX's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018
Period end date 6/30/2024 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019 6/30/2018
Growth Metrics		 - - - - - - -
Revenue Growth		 -2.78% 6.14% 11.16% 9.44% 9.98% 7.65% 0.00%
EBITDA Growth		 -0.96% 53.55% 24.27% -11.62% 63.67% 354.93% 0.00%
EBIT Growth		 -2.59% 96.26% 21.00% 69.01% 1,215.60% 95.67% 0.00%
NOPAT Growth		 2.13% 38.82% 55.10% -15.63% 287.06% 136.23% 0.00%
Net Income Growth		 6.56% 47.19% 63.92% 68.46% -29.14% 169.04% 0.00%
EPS Growth		 10.18% 45.22% 61.97% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 -14.24% 4.63% 148.84% -68.91% 2,248.73% 138.32% 0.00%
Free Cash Flow Firm Growth		 15.10% -70.75% 394.56% -145.47% 143.00% 0.00% 0.00%
Invested Capital Growth		 11.82% 16.40% -33.50% 42.80% -26.06% 0.00% 0.00%
Revenue Q/Q Growth		 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 7.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 13.09% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 18.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 18.84% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 20.26% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -0.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 -4.95% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 31.72% 29.78% 23.64%
EBITDA Margin		 11.58% 11.37% 7.86% 7.03% 8.70% 5.85% -2.47%
Operating Margin		 7.75% 7.74% 4.18% 3.84% 5.59% 1.75% -5.19%
EBIT Margin		 7.75% 7.74% 4.18% 3.84% 2.49% -0.25% -6.10%
Profit (Net Income) Margin		 6.62% 6.04% 4.35% 2.95% 1.92% 2.98% -4.64%
Tax Burden Percent		 82.11% 78.32% 110.72% 86.38% 77.05% -1,212.94% 76.09%
Interest Burden Percent		 103.95% 99.62% 93.96% 88.90% 100.00% 100.00% 100.00%
Effective Tax Rate		 17.89% 21.68% -10.72% 13.62% 22.95% 0.00% 0.00%
Return on Invested Capital (ROIC)		 32.68% 36.46% 22.70% 14.33% 17.53% 7.88% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 30.50% 36.72% -16.10% 11.32% 6.42% 20.08% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -11.36% -12.48% -0.59% 12.71% 45.19% 246.29% 0.00%
Return on Equity (ROE)		 21.32% 23.98% 22.11% 27.04% 62.72% 254.17% 0.00%
Cash Return on Invested Capital (CROIC)		 21.52% 21.30% 62.94% -20.92% 47.49% -192.12% 0.00%
Operating Return on Assets (OROA)		 13.43% 13.78% 7.26% 7.26% 5.26% -0.48% 0.00%
Return on Assets (ROA)		 11.46% 10.75% 7.55% 5.58% 4.05% 5.82% 0.00%
Return on Common Equity (ROCE)		 21.32% 23.98% 22.11% 27.04% 62.72% 254.17% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 20.30% 21.06% 18.91% 16.23% 48.12% 127.09% 0.00%
Net Operating Profit after Tax (NOPAT)		 32 32 23 15 17 4.51 -12
NOPAT Margin		 6.37% 6.06% 4.63% 3.32% 4.31% 1.22% -3.64%
Net Nonoperating Expense Percent (NNEP)		 2.17% -0.27% 38.80% 3.01% 11.11% -12.20% 0.00%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 68.28% 70.22% 76.36%
SG&A Expenses to Revenue		 18.31% 16.95% 16.26% 17.36% 4.28% 7.57% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 92.25% 92.26% 95.82% 96.16% 26.13% 28.03% 28.83%
Earnings before Interest and Taxes (EBIT)		 39 40 21 17 10 -0.90 -21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 59 59 39 31 35 22 -8.45
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 1.68 2.58 2.74 3.16 5.60 10.49 0.00
Price to Tangible Book Value (P/TBV)		 1.81 2.80 3.05 3.88 58.94 0.00 0.00
Price to Revenue (P/Rev)		 0.55 0.74 0.63 0.57 0.22 0.25 0.26
Price to Earnings (P/E)		 8.28 12.27 14.47 19.46 11.64 8.25 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 12.08% 8.15% 6.91% 5.14% 8.59% 12.12% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.08 3.54 3.45 2.46 1.91 1.65 0.00
Enterprise Value to Revenue (EV/Rev)		 0.43 0.63 0.56 0.67 0.40 0.51 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 3.69 5.57 7.16 9.53 4.58 8.77 0.00
Enterprise Value to EBIT (EV/EBIT)		 5.51 8.18 13.44 17.42 16.02 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 6.71 10.44 12.14 20.17 9.26 41.92 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 6.05 7.91 6.93 18.47 3.12 85.83 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 10.19 17.87 4.38 0.00 3.42 0.00 0.00
Leverage & Solvency		 - - - - - - -
Debt to Equity		 0.01 0.01 0.14 1.24 5.78 12.47 0.00
Long-Term Debt to Equity		 0.01 0.00 0.01 0.91 4.08 7.62 0.00
Financial Leverage		 -0.37 -0.34 0.04 1.12 7.04 12.27 0.00
Leverage Ratio		 1.86 2.23 2.93 4.85 15.48 21.82 0.00
Compound Leverage Factor		 1.93 2.22 2.75 4.31 15.48 21.82 0.00
Debt to Total Capital		 0.91% 0.67% 12.18% 55.45% 85.25% 92.58% 0.00%
Short-Term Debt to Total Capital		 0.39% 0.27% 11.67% 14.76% 25.10% 35.99% 0.00%
Long-Term Debt to Total Capital		 0.52% 0.40% 0.51% 40.69% 60.14% 56.59% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.09% 99.33% 87.82% 44.55% 14.75% 7.42% 0.00%
Debt to EBITDA		 0.03 0.02 0.41 3.22 2.65 5.00 0.00
Net Debt to EBITDA		 -1.04 -0.95 -0.85 1.36 2.02 4.57 0.00
Long-Term Debt to EBITDA		 0.01 0.01 0.02 2.36 1.87 3.05 0.00
Debt to NOPAT		 0.05 0.03 0.69 6.82 5.35 23.87 0.00
Net Debt to NOPAT		 -1.89 -1.78 -1.45 2.87 4.07 21.85 0.00
Long-Term Debt to NOPAT		 0.03 0.02 0.03 5.00 3.77 14.59 0.00
Altman Z-Score		 3.87 4.00 2.76 2.20 1.64 1.18 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - -
Current Ratio		 2.53 2.17 1.46 1.34 0.81 0.73 0.00
Quick Ratio		 2.27 1.96 1.27 1.33 0.81 0.73 0.00
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 21 19 63 -21 47 -110 0.00
Operating Cash Flow to CapEx		 405.42% 220.87% 154.35% 77.21% 1,207.54% 39.24% -110.65%
Free Cash Flow to Firm to Interest Expense		 41.48 23.39 49.13 -11.36 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 69.84 52.85 31.04 8.50 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 52.62 28.92 10.93 -2.51 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - -
Asset Turnover		 1.73 1.78 1.73 1.89 2.11 1.96 0.00
Accounts Receivable Turnover		 5.50 6.46 6.23 6.03 5.91 5.05 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 13.55 7.68 4.85 4.48 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 5.53 5.52 0.00
Days Sales Outstanding (DSO)		 66.37 56.46 58.61 60.52 61.74 72.23 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 66.04 66.16 0.00
Cash Conversion Cycle (CCC)		 66.37 56.46 58.61 60.52 -4.30 6.07 0.00
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 105 94 80 121 85 114 0.00
Invested Capital Turnover		 5.13 6.02 4.90 4.32 4.07 6.44 0.00
Increase / (Decrease) in Invested Capital		 11 13 -40 36 -30 114 0.00
Enterprise Value (EV)		 217 331 277 297 162 189 0.00
Market Capitalization		 279 387 310 255 90 90 90
Book Value per Share		 $9.63 $8.22 $6.17 $6.18 $1.24 $1.81 $0.00
Tangible Book Value per Share		 $8.94 $7.57 $5.52 $5.03 $0.12 ($1.29) $0.00
Total Capital		 167 151 129 181 109 116 0.00
Total Debt		 1.53 1.01 16 100 93 108 0.00
Total Long-Term Debt		 0.87 0.60 0.66 74 66 66 0.00
Net Debt		 -61 -56 -33 42 71 99 0.00
Capital Expenditures (CapEx)		 8.86 19 26 21 4.28 5.61 5.19
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 47 28 11 4.53 -14 3.36 0.00
Debt-free Net Working Capital (DFNWC)		 110 86 60 62 7.86 12 0.00
Net Working Capital (NWC)		 109 85 45 36 -20 -30 0.00
Net Nonoperating Expense (NNE)		 -1.28 0.12 1.38 1.63 9.68 -6.46 3.44
Net Nonoperating Obligations (NNO)		 -61 -56 -33 40 68 106 0.00
Total Depreciation and Amortization (D&A)		 19 19 18 14 25 22 12
Debt-free, Cash-free Net Working Capital to Revenue		 9.22% 5.42% 2.20% 1.02% -3.46% 0.91% 0.00%
Debt-free Net Working Capital to Revenue		 21.56% 16.39% 12.10% 14.07% 1.94% 3.32% 0.00%
Net Working Capital to Revenue		 21.43% 16.31% 9.04% 8.04% -4.84% -8.04% 0.00%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $1.90 $1.74 $0.00 $0.16 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 17.70M 18.20M 18.25M 18.40M 13.05M 0.00 0.00
Adjusted Diluted Earnings per Share		 $1.84 $1.67 $0.00 $0.15 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 18.26M 18.89M 18.25M 18.40M 13.05M 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 16.80M 18.30M 18.25M 18.40M 13.05M 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 32 32 14 15 17 4.51 -12
Normalized NOPAT Margin		 6.37% 6.06% 2.93% 3.32% 4.31% 1.22% -3.64%
Pre Tax Income Margin		 8.06% 7.71% 3.93% 3.42% 2.49% -0.25% -6.10%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 76.71 51.11 16.00 9.01 0.00 0.00 0.00
NOPAT to Interest Expense		 62.99 40.03 17.72 7.78 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 59.48 27.18 -4.11 -2.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 45.76 16.10 -2.39 -3.22 0.00 0.00 0.00
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 30.56% 1.56% 14.59% -0.92%
Augmented Payout Ratio		 64.05% 0.87% 15.87% 38.77% 1.56% 14.59% -0.92%

Quarterly Metrics And Ratios for IBEX

This table displays calculated financial ratios and metrics derived from IBEX's official financial filings.

Metric Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 6.07% 4.10% 0.08% -3.62% -4.80% -2.50% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 36.33% 0.66% 30.84% -8.90% -25.82% 8.31% 0.00% 0.00% 0.00% 0.00%
EBIT Growth		 71.70% 9.13% 54.94% -13.55% -39.33% 8.62% 0.00% 0.00% 0.00% 0.00%
NOPAT Growth		 65.66% 2.55% 112.50% -10.33% -38.92% 6.20% 0.00% 0.00% 0.00% 0.00%
Net Income Growth		 52.56% 1.43% 118.29% -8.59% -34.47% 13.83% 0.00% 0.00% 0.00% 0.00%
EPS Growth		 72.73% 10.26% 129.17% -3.39% -32.65% 11.43% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 169.70% -10.62% -0.07% -15.76% -130.93% 56.13% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Growth		 95.09% 90.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 13.46% 16.11% 11.82% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 8.45% 4.16% -1.79% -4.40% 6.44% 0.14% -5.42% -5.58% 9.01% 0.00%
EBITDA Q/Q Growth		 20.45% -22.98% 8.24% 35.77% -11.07% 0.11% -24.64% 10.55% 29.85% 0.00%
EBIT Q/Q Growth		 31.19% -29.35% 14.07% 62.40% -16.61% 0.30% -36.36% 13.97% 49.30% 0.00%
NOPAT Q/Q Growth		 32.19% -24.80% -4.63% 74.75% -18.17% 55.82% -59.76% 19.04% 42.27% 0.00%
Net Income Q/Q Growth		 23.06% -23.50% -4.51% 69.71% -18.18% 64.63% -60.01% 21.67% 42.11% 0.00%
EPS Q/Q Growth		 32.56% -21.82% -3.51% 72.73% -15.38% 62.50% -59.32% 20.41% 40.00% 0.00%
Operating Cash Flow Q/Q Growth		 -85.30% -55.45% 52.41% 798.29% -118.85% -50.19% 28.49% 156.36% -4.84% 0.00%
Free Cash Flow Firm Q/Q Growth		 37.90% -445.18% 98.51% 2.29% -16.35% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 11.20% 5.43% -4.95% 1.81% 13.80% 1.54% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 100.00% 100.00% 246.92% 31.32% 27.71% 29.22% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 11.53% 10.38% 14.03% 12.73% 8.97% 10.73% 10.74% 13.47% 11.51% 9.66%
Operating Margin		 8.48% 7.01% 10.33% 8.90% 5.24% 6.69% 6.68% 9.92% 8.22% 6.00%
EBIT Margin		 8.48% 7.01% 10.33% 8.90% 5.24% 6.69% 6.68% 9.92% 8.22% 6.00%
Profit (Net Income) Margin		 6.59% 5.81% 7.91% 8.13% 4.58% 5.96% 3.62% 8.57% 6.65% 5.10%
Tax Burden Percent		 79.77% 79.17% 74.38% 88.96% 82.68% 84.25% 54.23% 85.77% 82.12% 86.17%
Interest Burden Percent		 97.41% 104.63% 102.85% 102.72% 105.77% 105.79% 100.12% 100.77% 98.59% 98.70%
Effective Tax Rate		 20.23% 20.83% 25.62% 11.04% 17.32% 15.75% 45.77% 14.23% 17.88% 13.83%
Return on Invested Capital (ROIC)		 30.58% 27.77% 39.46% 73.15% 41.12% 61.66% 20.24% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 32.02% 27.22% 38.99% 72.04% 39.74% 60.33% 20.23% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 -4.14% -10.14% -14.52% -22.27% -12.22% -23.61% -7.61% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 26.44% 17.63% 24.93% 50.87% 28.90% 38.06% 12.63% 0.00% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)		 18.88% 16.81% 21.52% 0.00% 0.00% 0.00% 19.80% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 15.50% 11.97% 17.90% 15.62% 9.02% 11.76% 11.89% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 12.05% 9.91% 13.69% 14.28% 7.88% 10.48% 6.45% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 26.44% 17.63% 24.93% 50.87% 28.90% 38.06% 12.63% 0.00% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)		 33.92% 19.73% 0.00% 17.78% 18.76% 20.82% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 9.51 7.20 9.57 10 5.74 7.02 4.50 11 9.40 6.61
NOPAT Margin		 6.76% 5.55% 7.69% 7.92% 4.33% 5.63% 3.62% 8.51% 6.75% 5.17%
Net Nonoperating Expense Percent (NNEP)		 -1.44% 0.55% 0.46% 1.11% 1.38% 1.33% 0.01% 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)		 6.66% - - - 3.66% - - - - -
Cost of Revenue to Revenue		 0.00% 0.00% -146.92% 68.68% 72.29% 70.78% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 18.27% 20.21% 17.41% 18.59% 18.74% 18.49% 19.06% 16.83% 16.87% 15.11%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 91.52% 92.99% 236.59% 22.42% 22.47% 22.54% 93.32% 90.08% 91.78% 94.00%
Earnings before Interest and Taxes (EBIT)		 12 9.09 13 11 6.95 8.33 8.31 13 11 7.67
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 16 13 17 16 12 13 13 18 16 12
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 3.31 1.96 1.68 1.70 2.18 1.81 2.58 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 3.71 2.11 1.81 1.84 2.36 1.96 2.80 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.69 0.65 0.55 0.53 0.66 0.54 0.74 0.00 0.00 0.00
Price to Earnings (P/E)		 9.75 9.94 8.28 9.57 11.64 8.71 12.27 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 10.26% 10.06% 12.08% 10.44% 8.59% 11.49% 8.15% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 3.05 2.49 2.08 2.02 2.71 2.33 3.54 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 0.72 0.54 0.43 0.44 0.57 0.43 0.63 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 5.91 4.66 3.69 4.05 5.20 3.67 5.57 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 8.28 6.84 5.51 6.36 8.00 5.39 8.18 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 10.30 8.45 6.71 8.10 10.27 6.90 10.44 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 9.91 7.86 6.05 6.18 7.70 4.93 7.91 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 17.17 15.94 10.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.31 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Long-Term Debt to Equity		 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.13 -0.37 -0.37 -0.31 -0.31 -0.39 -0.38 0.00 0.00 0.00
Leverage Ratio		 2.15 1.84 1.86 1.82 1.91 1.89 2.23 0.00 0.00 0.00
Compound Leverage Factor		 2.10 1.92 1.91 1.87 2.02 2.00 2.23 0.00 0.00 0.00
Debt to Total Capital		 23.74% 0.87% 0.91% 0.87% 0.64% 0.62% 0.67% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 23.25% 0.40% 0.39% 0.36% 0.28% 0.25% 0.27% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.49% 0.46% 0.52% 0.51% 0.36% 0.37% 0.40% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 76.26% 99.13% 99.09% 99.13% 99.36% 99.38% 99.33% 0.00% 0.00% 0.00%
Debt to EBITDA		 0.54 0.03 0.03 0.03 0.02 0.02 0.02 0.00 0.00 0.00
Net Debt to EBITDA		 0.22 -1.03 -1.04 -0.90 -0.85 -1.01 -0.95 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.00 0.00 0.00
Debt to NOPAT		 0.93 0.05 0.05 0.05 0.04 0.03 0.03 0.00 0.00 0.00
Net Debt to NOPAT		 0.38 -1.87 -1.89 -1.80 -1.68 -1.90 -1.78 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.02 0.02 0.03 0.03 0.02 0.02 0.02 0.00 0.00 0.00
Altman Z-Score		 3.62 3.68 3.57 3.45 3.47 3.27 3.63 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 1.44 2.42 2.53 2.42 2.28 2.27 2.17 0.00 0.00 0.00
Quick Ratio		 1.28 2.17 2.27 2.18 2.07 2.07 1.96 0.00 0.00 0.00
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -5.03 -8.10 -1.49 -100 -102 -88 0.00 0.00 0.00 0.00
Operating Cash Flow to CapEx		 26.42% 213.83% 784.77% 675.99% -56.60% 423.20% 468.56% 364.27% 66.60% 156.32%
Free Cash Flow to Firm to Interest Expense		 -8.11 -50.01 -8.49 -806.57 -922.11 -845.85 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 1.84 47.91 99.55 92.19 -14.75 83.50 72.95 129.23 17.64 37.58
Operating Cash Flow Less CapEx to Interest Expense		 -5.13 25.51 86.87 78.55 -40.80 63.77 57.38 93.75 -8.85 13.54
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 1.83 1.71 1.73 1.76 1.72 1.76 1.78 0.00 0.00 0.00
Accounts Receivable Turnover		 4.62 5.23 5.50 4.91 4.89 5.76 6.46 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 16.16 14.28 13.72 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 31.81 10.26 4.84 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 78.98 69.82 66.37 74.28 74.59 63.33 56.46 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 11.47 35.56 75.49 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 78.98 69.82 66.37 62.81 39.03 -12.16 56.46 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 123 110 105 110 108 95 94 0.00 0.00 0.00
Invested Capital Turnover		 4.52 5.00 5.13 9.24 9.50 10.95 5.59 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 15 15 11 110 108 95 0.00 0.00 0.00 0.00
Enterprise Value (EV)		 374 275 217 222 293 222 331 0.00 0.00 0.00
Market Capitalization		 360 336 279 271 341 283 387 445 453 342
Book Value per Share		 $6.50 $10.18 $9.63 $9.07 $8.70 $8.52 $8.22 $0.00 $0.00 $0.00
Tangible Book Value per Share		 $5.79 $9.48 $8.94 $8.39 $8.04 $7.88 $7.57 $0.00 $0.00 $0.00
Total Capital		 143 173 167 161 157 157 151 0.00 0.00 0.00
Total Debt		 34 1.50 1.53 1.41 1.00 0.98 1.01 0.00 0.00 0.00
Total Long-Term Debt		 0.70 0.80 0.87 0.82 0.56 0.58 0.60 0.00 0.00 0.00
Net Debt		 14 -61 -61 -49 -48 -61 -56 0.00 0.00 0.00
Capital Expenditures (CapEx)		 4.32 3.63 2.22 1.69 2.89 2.05 3.72 3.73 7.95 3.56
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 61 49 47 51 47 32 28 0.00 0.00 0.00
Debt-free Net Working Capital (DFNWC)		 82 111 110 101 96 94 86 0.00 0.00 0.00
Net Working Capital (NWC)		 48 111 109 101 95 94 85 0.00 0.00 0.00
Net Nonoperating Expense (NNE)		 0.25 -0.33 -0.27 -0.27 -0.33 -0.41 -0.01 -0.09 0.13 0.09
Net Nonoperating Obligations (NNO)		 14 -61 -61 -49 -48 -61 -56 0.00 0.00 0.00
Total Depreciation and Amortization (D&A)		 4.29 4.37 4.61 4.87 4.95 5.04 5.05 4.67 4.58 4.68
Debt-free, Cash-free Net Working Capital to Revenue		 11.77% 9.57% 9.22% 9.93% 9.10% 6.18% 5.42% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 15.64% 21.70% 21.56% 19.90% 18.65% 18.12% 16.39% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 9.27% 21.56% 21.43% 19.78% 18.56% 18.04% 16.31% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.61 $0.45 $0.56 $0.59 $0.34 $0.41 $0.25 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 15.13M 16.88M 17.70M 17.47M 17.89M 18.29M 18.20M 0.00 0.00 0.00
Adjusted Diluted Earnings per Share		 $0.57 $0.43 $0.55 $0.57 $0.33 $0.39 $0.24 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 16.46M 17.49M 18.26M 18.04M 18.44M 18.90M 18.89M 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.19M 16.76M 16.80M 17.21M 17.57M 17.94M 18.30M 0.00 0.00 0.00
Normalized Net Operating Profit after Tax (NOPAT)		 9.51 7.20 9.57 10 5.74 7.02 4.50 11 9.40 6.61
Normalized NOPAT Margin		 6.76% 5.55% 7.69% 7.92% 4.33% 5.63% 3.62% 8.51% 6.75% 5.17%
Pre Tax Income Margin		 8.26% 7.33% 10.63% 9.14% 5.54% 7.07% 6.68% 10.00% 8.10% 5.92%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 19.24 56.12 73.54 90.98 62.59 80.11 34.75 124.30 38.17 51.82
NOPAT to Interest Expense		 15.35 44.43 54.70 80.94 51.74 67.49 18.85 106.60 31.34 44.66
EBIT Less CapEx to Interest Expense		 12.27 33.72 60.85 77.35 36.53 60.38 19.18 88.82 11.68 27.78
NOPAT Less CapEx to Interest Expense		 8.38 22.02 42.01 67.31 25.69 47.76 3.28 71.13 4.85 20.62
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 169.54% 72.66% 64.05% 65.50% 35.08% 5.64% 0.87% 0.00% 0.00% 0.00%

Frequently Asked Questions About IBEX's Financials

When does IBEX's financial year end?

According to the most recent income statement we have on file, IBEX's fiscal year ends in June. Their fiscal year 2024 ended on June 30, 2024.

How has IBEX's net income changed over the last 6 years?

IBEX's net income appears to be on an upward trend, with a most recent value of $33.66 million in 2024, falling from -$15.88 million in 2018. The previous period was $31.58 million in 2023. Check out IBEX's forecast to explore projected trends and price targets.

What is IBEX's operating income?
IBEX's total operating income in 2024 was $39.43 million, based on the following breakdown:
  • Total Gross Profit: $508.57 million
  • Total Operating Expenses: $469.14 million
How has IBEX revenue changed over the last 6 years?

Over the last 6 years, IBEX's total revenue changed from $342.20 million in 2018 to $508.57 million in 2024, a change of 48.6%.

How much debt does IBEX have?

IBEX's total liabilities were at $128.11 million at the end of 2024, a 10.6% decrease from 2023, and a 28.7% decrease since 2019.

How much cash does IBEX have?

In the past 5 years, IBEX's cash and equivalents has ranged from $8.87 million in 2019 to $62.72 million in 2024, and is currently $62.72 million as of their latest financial filing in 2024.

How has IBEX's book value per share changed over the last 6 years?

Over the last 6 years, IBEX's book value per share changed from 0.00 in 2018 to 9.63 in 2024, a change of 963.1%.


Related Companies

This page (NASDAQ:IBEX) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored